Original Research

Page 12

JCP
Impact of SUD on COVID-19 Outcomes
JCP
Machine Learning Prediction of ECT Responses
PCC
Burden of Psychiatric Disorders in Moyamoya Disease
JCP
Omega-3 Fatty Acids for MDD With High Inflammation
PCC
Suicide Methods of Depressed and Bipolar Individuals
JCP
Intravenous Scopolamine Versus Active Placebo in MDD
PCC
Computer Vision Syndrome, Insomnia, and Migraine
JCP
Remission of Psychotic Late-Life Depression Following ECT
PCC
Substance Abuse and Metabolic Syndrome
JCP
Faces Scales to Measure Anxiety and Anger
JCP
Very Low-Level Transcranial Photobiomodulation for MDD
JCP
Cannabidiol for Treatment-Resistant Anxiety
JCP
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics
JCP
Add-on Pramipexole for Schizophrenia
JCP
Depression Severity, Psychotic Depression, and Suicide Risk
JCP
Predictors of Recurrence or Persistence in Panic Disorder
PCC
Suicidal Behaviors Among Youth
JCP
Amphetamine Extended-Release Tablets for Adult ADHD
JCP
Treatment-Resistant Mood Disorders in LGBTQ People
PCC
Criminal Behavior in Bipolar I Disorder
PCC
Vaccination Among Children With Developmental Delay and Their Siblings
JCP
Elevated CCK With ARFID
JCP
Sexual Health, Substance Use, and ADHD in College Students
PCC
Tardive Dyskinesia in a Community Mental Health Center